カテゴリー： Market Monitor Global, 世界, 医療/バイオ

BCG&結核ワクチンの世界市場見通し2023年-2029年

◆英語タイトル：BCG and Tuberculosis Vaccine Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5707）◆商品コード：MMG23JU5707
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：78
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global BCG and Tuberculosis Vaccine Market 調査レポートは次の情報を含め、グローバルにおけるのBCG&結核ワクチン市場規模と予測を収録しています。・世界のBCG&結核ワクチン市場：売上、2018年-2023年、2024年-2029年
・世界のBCG&結核ワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のBCG&結核ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「免疫ワクチン」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

BCG&結核ワクチンのグローバル主要企業は、Merck、 Japan BCG Lab、 Serum Institute of India、 AJ Vaccines、 BioFarma、 GreenSignal Bio Pharma、 China National Biotec、 Biomed Lublin、 Taj Pharmaceuticals、 Ataulpho de Paiva、 IVAC-Institute of Vaccines and Medical Biologicals、 Queen Saovabha Mem. Inst、 Microgenなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、BCG&結核ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のBCG&結核ワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界のBCG&結核ワクチン市場：タイプ別市場シェア、2022年
・免疫ワクチン、治療ワクチン

世界のBCG&結核ワクチン市場：用途別、2018年-2023年、2024年-2029年
世界のBCG&結核ワクチン市場：用途別市場シェア、2022年
・自主調達、ユニセフ、その他

世界のBCG&結核ワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界のBCG&結核ワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるBCG&結核ワクチンのグローバル売上、2018年-2023年
・主要企業におけるBCG&結核ワクチンのグローバル売上シェア、2022年
・主要企業におけるBCG&結核ワクチンのグローバル販売量、2018年-2023年
・主要企業におけるBCG&結核ワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Merck、 Japan BCG Lab、 Serum Institute of India、 AJ Vaccines、 BioFarma、 GreenSignal Bio Pharma、 China National Biotec、 Biomed Lublin、 Taj Pharmaceuticals、 Ataulpho de Paiva、 IVAC-Institute of Vaccines and Medical Biologicals、 Queen Saovabha Mem. Inst、 Microgen

*************************************************************

・調査・分析レポートの概要
BCG&結核ワクチン市場の定義
市場セグメント
世界のBCG&結核ワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のBCG&結核ワクチン市場規模
世界のBCG&結核ワクチン市場規模：2022年 VS 2029年
世界のBCG&結核ワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのBCG&結核ワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のBCG&結核ワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：免疫ワクチン、治療ワクチン
BCG&結核ワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：自主調達、ユニセフ、その他
BCG&結核ワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別BCG&結核ワクチン市場規模 2022年と2029年
地域別BCG&結核ワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Merck、 Japan BCG Lab、 Serum Institute of India、 AJ Vaccines、 BioFarma、 GreenSignal Bio Pharma、 China National Biotec、 Biomed Lublin、 Taj Pharmaceuticals、 Ataulpho de Paiva、 IVAC-Institute of Vaccines and Medical Biologicals、 Queen Saovabha Mem. Inst、 Microgen
...

Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
This report aims to provide a comprehensive presentation of the global market for BCG and Tuberculosis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BCG and Tuberculosis Vaccine. This report contains market size and forecasts of BCG and Tuberculosis Vaccine in global, including the following market information:
Global BCG and Tuberculosis Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global BCG and Tuberculosis Vaccine Market Sales, 2018-2023, 2024-2029, (Units)
Global top five BCG and Tuberculosis Vaccine companies in 2022 (%)
The global BCG and Tuberculosis Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Immune Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of BCG and Tuberculosis Vaccine include Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin and Taj Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the BCG and Tuberculosis Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global BCG and Tuberculosis Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global BCG and Tuberculosis Vaccine Market Segment Percentages, by Type, 2022 (%)
Immune Vaccine
Therapy Vaccine
Global BCG and Tuberculosis Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global BCG and Tuberculosis Vaccine Market Segment Percentages, by Application, 2022 (%)
Self-Procurement
UNICEF
Others
Global BCG and Tuberculosis Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global BCG and Tuberculosis Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies BCG and Tuberculosis Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies BCG and Tuberculosis Vaccine revenues share in global market, 2022 (%)
Key companies BCG and Tuberculosis Vaccine sales in global market, 2018-2023 (Estimated), (Units)
Key companies BCG and Tuberculosis Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC-Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen
Outline of Major Chapters:
Chapter 1: Introduces the definition of BCG and Tuberculosis Vaccine, market overview.
Chapter 2: Global BCG and Tuberculosis Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of BCG and Tuberculosis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of BCG and Tuberculosis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global BCG and Tuberculosis Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 BCG and Tuberculosis Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global BCG and Tuberculosis Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global BCG and Tuberculosis Vaccine Overall Market Size
2.1 Global BCG and Tuberculosis Vaccine Market Size: 2022 VS 2029
2.2 Global BCG and Tuberculosis Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global BCG and Tuberculosis Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top BCG and Tuberculosis Vaccine Players in Global Market
3.2 Top Global BCG and Tuberculosis Vaccine Companies Ranked by Revenue
3.3 Global BCG and Tuberculosis Vaccine Revenue by Companies
3.4 Global BCG and Tuberculosis Vaccine Sales by Companies
3.5 Global BCG and Tuberculosis Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 BCG and Tuberculosis Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers BCG and Tuberculosis Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 BCG and Tuberculosis Vaccine Players in Global Market
3.8.1 List of Global Tier 1 BCG and Tuberculosis Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 BCG and Tuberculosis Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global BCG and Tuberculosis Vaccine Market Size Markets, 2022 & 2029
4.1.2 Immune Vaccine
4.1.3 Therapy Vaccine
4.2 By Type – Global BCG and Tuberculosis Vaccine Revenue & Forecasts
4.2.1 By Type – Global BCG and Tuberculosis Vaccine Revenue, 2018-2023
4.2.2 By Type – Global BCG and Tuberculosis Vaccine Revenue, 2024-2029
4.2.3 By Type – Global BCG and Tuberculosis Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global BCG and Tuberculosis Vaccine Sales & Forecasts
4.3.1 By Type – Global BCG and Tuberculosis Vaccine Sales, 2018-2023
4.3.2 By Type – Global BCG and Tuberculosis Vaccine Sales, 2024-2029
4.3.3 By Type – Global BCG and Tuberculosis Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global BCG and Tuberculosis Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global BCG and Tuberculosis Vaccine Market Size, 2022 & 2029
5.1.2 Self-Procurement
5.1.3 UNICEF
5.1.4 Others
5.2 By Application – Global BCG and Tuberculosis Vaccine Revenue & Forecasts
5.2.1 By Application – Global BCG and Tuberculosis Vaccine Revenue, 2018-2023
5.2.2 By Application – Global BCG and Tuberculosis Vaccine Revenue, 2024-2029
5.2.3 By Application – Global BCG and Tuberculosis Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global BCG and Tuberculosis Vaccine Sales & Forecasts
5.3.1 By Application – Global BCG and Tuberculosis Vaccine Sales, 2018-2023
5.3.2 By Application – Global BCG and Tuberculosis Vaccine Sales, 2024-2029
5.3.3 By Application – Global BCG and Tuberculosis Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global BCG and Tuberculosis Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global BCG and Tuberculosis Vaccine Market Size, 2022 & 2029
6.2 By Region – Global BCG and Tuberculosis Vaccine Revenue & Forecasts
6.2.1 By Region – Global BCG and Tuberculosis Vaccine Revenue, 2018-2023
6.2.2 By Region – Global BCG and Tuberculosis Vaccine Revenue, 2024-2029
6.2.3 By Region – Global BCG and Tuberculosis Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global BCG and Tuberculosis Vaccine Sales & Forecasts
6.3.1 By Region – Global BCG and Tuberculosis Vaccine Sales, 2018-2023
6.3.2 By Region – Global BCG and Tuberculosis Vaccine Sales, 2024-2029
6.3.3 By Region – Global BCG and Tuberculosis Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America BCG and Tuberculosis Vaccine Revenue, 2018-2029
6.4.2 By Country – North America BCG and Tuberculosis Vaccine Sales, 2018-2029
6.4.3 US BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.4.4 Canada BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.4.5 Mexico BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe BCG and Tuberculosis Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe BCG and Tuberculosis Vaccine Sales, 2018-2029
6.5.3 Germany BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.5.4 France BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.5.5 U.K. BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.5.6 Italy BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.5.7 Russia BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.5.9 Benelux BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia BCG and Tuberculosis Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia BCG and Tuberculosis Vaccine Sales, 2018-2029
6.6.3 China BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.6.4 Japan BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.6.5 South Korea BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.6.7 India BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America BCG and Tuberculosis Vaccine Revenue, 2018-2029
6.7.2 By Country – South America BCG and Tuberculosis Vaccine Sales, 2018-2029
6.7.3 Brazil BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.7.4 Argentina BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa BCG and Tuberculosis Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa BCG and Tuberculosis Vaccine Sales, 2018-2029
6.8.3 Turkey BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.8.4 Israel BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.8.6 UAE BCG and Tuberculosis Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck BCG and Tuberculosis Vaccine Major Product Offerings
7.1.4 Merck BCG and Tuberculosis Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Japan BCG Lab
7.2.1 Japan BCG Lab Company Summary
7.2.2 Japan BCG Lab Business Overview
7.2.3 Japan BCG Lab BCG and Tuberculosis Vaccine Major Product Offerings
7.2.4 Japan BCG Lab BCG and Tuberculosis Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Japan BCG Lab Key News & Latest Developments
7.3 Serum Institute of India
7.3.1 Serum Institute of India Company Summary
7.3.2 Serum Institute of India Business Overview
7.3.3 Serum Institute of India BCG and Tuberculosis Vaccine Major Product Offerings
7.3.4 Serum Institute of India BCG and Tuberculosis Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Serum Institute of India Key News & Latest Developments
7.4 AJ Vaccines
7.4.1 AJ Vaccines Company Summary
7.4.2 AJ Vaccines Business Overview
7.4.3 AJ Vaccines BCG and Tuberculosis Vaccine Major Product Offerings
7.4.4 AJ Vaccines BCG and Tuberculosis Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 AJ Vaccines Key News & Latest Developments
7.5 BioFarma
7.5.1 BioFarma Company Summary
7.5.2 BioFarma Business Overview
7.5.3 BioFarma BCG and Tuberculosis Vaccine Major Product Offerings
7.5.4 BioFarma BCG and Tuberculosis Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 BioFarma Key News & Latest Developments
7.6 GreenSignal Bio Pharma
7.6.1 GreenSignal Bio Pharma Company Summary
7.6.2 GreenSignal Bio Pharma Business Overview
7.6.3 GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Major Product Offerings
7.6.4 GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 GreenSignal Bio Pharma Key News & Latest Developments
7.7 China National Biotec
7.7.1 China National Biotec Company Summary
7.7.2 China National Biotec Business Overview
7.7.3 China National Biotec BCG and Tuberculosis Vaccine Major Product Offerings
7.7.4 China National Biotec BCG and Tuberculosis Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 China National Biotec Key News & Latest Developments
7.8 Biomed Lublin
7.8.1 Biomed Lublin Company Summary
7.8.2 Biomed Lublin Business Overview
7.8.3 Biomed Lublin BCG and Tuberculosis Vaccine Major Product Offerings
7.8.4 Biomed Lublin BCG and Tuberculosis Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Biomed Lublin Key News & Latest Developments
7.9 Taj Pharmaceuticals
7.9.1 Taj Pharmaceuticals Company Summary
7.9.2 Taj Pharmaceuticals Business Overview
7.9.3 Taj Pharmaceuticals BCG and Tuberculosis Vaccine Major Product Offerings
7.9.4 Taj Pharmaceuticals BCG and Tuberculosis Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Taj Pharmaceuticals Key News & Latest Developments
7.10 Ataulpho de Paiva
7.10.1 Ataulpho de Paiva Company Summary
7.10.2 Ataulpho de Paiva Business Overview
7.10.3 Ataulpho de Paiva BCG and Tuberculosis Vaccine Major Product Offerings
7.10.4 Ataulpho de Paiva BCG and Tuberculosis Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 Ataulpho de Paiva Key News & Latest Developments
7.11 IVAC-Institute of Vaccines and Medical Biologicals
7.11.1 IVAC-Institute of Vaccines and Medical Biologicals Company Summary
7.11.2 IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Business Overview
7.11.3 IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Major Product Offerings
7.11.4 IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 IVAC-Institute of Vaccines and Medical Biologicals Key News & Latest Developments
7.12 Queen Saovabha Mem. Inst
7.12.1 Queen Saovabha Mem. Inst Company Summary
7.12.2 Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Business Overview
7.12.3 Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Major Product Offerings
7.12.4 Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 Queen Saovabha Mem. Inst Key News & Latest Developments
7.13 Microgen
7.13.1 Microgen Company Summary
7.13.2 Microgen BCG and Tuberculosis Vaccine Business Overview
7.13.3 Microgen BCG and Tuberculosis Vaccine Major Product Offerings
7.13.4 Microgen BCG and Tuberculosis Vaccine Sales and Revenue in Global (2018-2023)
7.13.5 Microgen Key News & Latest Developments
8 Global BCG and Tuberculosis Vaccine Production Capacity, Analysis
8.1 Global BCG and Tuberculosis Vaccine Production Capacity, 2018-2029
8.2 BCG and Tuberculosis Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global BCG and Tuberculosis Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 BCG and Tuberculosis Vaccine Supply Chain Analysis
10.1 BCG and Tuberculosis Vaccine Industry Value Chain
10.2 BCG and Tuberculosis Vaccine Upstream Market
10.3 BCG and Tuberculosis Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 BCG and Tuberculosis Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of BCG and Tuberculosis Vaccine in Global Market
Table 2. Top BCG and Tuberculosis Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global BCG and Tuberculosis Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global BCG and Tuberculosis Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global BCG and Tuberculosis Vaccine Sales by Companies, (Units), 2018-2023
Table 6. Global BCG and Tuberculosis Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers BCG and Tuberculosis Vaccine Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers BCG and Tuberculosis Vaccine Product Type
Table 9. List of Global Tier 1 BCG and Tuberculosis Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 BCG and Tuberculosis Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global BCG and Tuberculosis Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global BCG and Tuberculosis Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global BCG and Tuberculosis Vaccine Sales (Units), 2018-2023
Table 15. By Type - Global BCG and Tuberculosis Vaccine Sales (Units), 2024-2029
Table 16. By Application – Global BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global BCG and Tuberculosis Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global BCG and Tuberculosis Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global BCG and Tuberculosis Vaccine Sales (Units), 2018-2023
Table 20. By Application - Global BCG and Tuberculosis Vaccine Sales (Units), 2024-2029
Table 21. By Region – Global BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global BCG and Tuberculosis Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global BCG and Tuberculosis Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global BCG and Tuberculosis Vaccine Sales (Units), 2018-2023
Table 25. By Region - Global BCG and Tuberculosis Vaccine Sales (Units), 2024-2029
Table 26. By Country - North America BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America BCG and Tuberculosis Vaccine Sales, (Units), 2018-2023
Table 29. By Country - North America BCG and Tuberculosis Vaccine Sales, (Units), 2024-2029
Table 30. By Country - Europe BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe BCG and Tuberculosis Vaccine Sales, (Units), 2018-2023
Table 33. By Country - Europe BCG and Tuberculosis Vaccine Sales, (Units), 2024-2029
Table 34. By Region - Asia BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia BCG and Tuberculosis Vaccine Sales, (Units), 2018-2023
Table 37. By Region - Asia BCG and Tuberculosis Vaccine Sales, (Units), 2024-2029
Table 38. By Country - South America BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America BCG and Tuberculosis Vaccine Sales, (Units), 2018-2023
Table 41. By Country - South America BCG and Tuberculosis Vaccine Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa BCG and Tuberculosis Vaccine Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa BCG and Tuberculosis Vaccine Sales, (Units), 2024-2029
Table 46. Merck Company Summary
Table 47. Merck BCG and Tuberculosis Vaccine Product Offerings
Table 48. Merck BCG and Tuberculosis Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Merck Key News & Latest Developments
Table 50. Japan BCG Lab Company Summary
Table 51. Japan BCG Lab BCG and Tuberculosis Vaccine Product Offerings
Table 52. Japan BCG Lab BCG and Tuberculosis Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Japan BCG Lab Key News & Latest Developments
Table 54. Serum Institute of India Company Summary
Table 55. Serum Institute of India BCG and Tuberculosis Vaccine Product Offerings
Table 56. Serum Institute of India BCG and Tuberculosis Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Serum Institute of India Key News & Latest Developments
Table 58. AJ Vaccines Company Summary
Table 59. AJ Vaccines BCG and Tuberculosis Vaccine Product Offerings
Table 60. AJ Vaccines BCG and Tuberculosis Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. AJ Vaccines Key News & Latest Developments
Table 62. BioFarma Company Summary
Table 63. BioFarma BCG and Tuberculosis Vaccine Product Offerings
Table 64. BioFarma BCG and Tuberculosis Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. BioFarma Key News & Latest Developments
Table 66. GreenSignal Bio Pharma Company Summary
Table 67. GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Product Offerings
Table 68. GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. GreenSignal Bio Pharma Key News & Latest Developments
Table 70. China National Biotec Company Summary
Table 71. China National Biotec BCG and Tuberculosis Vaccine Product Offerings
Table 72. China National Biotec BCG and Tuberculosis Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. China National Biotec Key News & Latest Developments
Table 74. Biomed Lublin Company Summary
Table 75. Biomed Lublin BCG and Tuberculosis Vaccine Product Offerings
Table 76. Biomed Lublin BCG and Tuberculosis Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Biomed Lublin Key News & Latest Developments
Table 78. Taj Pharmaceuticals Company Summary
Table 79. Taj Pharmaceuticals BCG and Tuberculosis Vaccine Product Offerings
Table 80. Taj Pharmaceuticals BCG and Tuberculosis Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Taj Pharmaceuticals Key News & Latest Developments
Table 82. Ataulpho de Paiva Company Summary
Table 83. Ataulpho de Paiva BCG and Tuberculosis Vaccine Product Offerings
Table 84. Ataulpho de Paiva BCG and Tuberculosis Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Ataulpho de Paiva Key News & Latest Developments
Table 86. IVAC-Institute of Vaccines and Medical Biologicals Company Summary
Table 87. IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Product Offerings
Table 88. IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. IVAC-Institute of Vaccines and Medical Biologicals Key News & Latest Developments
Table 90. Queen Saovabha Mem. Inst Company Summary
Table 91. Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Product Offerings
Table 92. Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Queen Saovabha Mem. Inst Key News & Latest Developments
Table 94. Microgen Company Summary
Table 95. Microgen BCG and Tuberculosis Vaccine Product Offerings
Table 96. Microgen BCG and Tuberculosis Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Microgen Key News & Latest Developments
Table 98. BCG and Tuberculosis Vaccine Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 99. Global BCG and Tuberculosis Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global BCG and Tuberculosis Vaccine Production by Region, 2018-2023 (Units)
Table 101. Global BCG and Tuberculosis Vaccine Production by Region, 2024-2029 (Units)
Table 102. BCG and Tuberculosis Vaccine Market Opportunities & Trends in Global Market
Table 103. BCG and Tuberculosis Vaccine Market Drivers in Global Market
Table 104. BCG and Tuberculosis Vaccine Market Restraints in Global Market
Table 105. BCG and Tuberculosis Vaccine Raw Materials
Table 106. BCG and Tuberculosis Vaccine Raw Materials Suppliers in Global Market
Table 107. Typical BCG and Tuberculosis Vaccine Downstream
Table 108. BCG and Tuberculosis Vaccine Downstream Clients in Global Market
Table 109. BCG and Tuberculosis Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. BCG and Tuberculosis Vaccine Segment by Type in 2022
Figure 2. BCG and Tuberculosis Vaccine Segment by Application in 2022
Figure 3. Global BCG and Tuberculosis Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global BCG and Tuberculosis Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global BCG and Tuberculosis Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. BCG and Tuberculosis Vaccine Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by BCG and Tuberculosis Vaccine Revenue in 2022
Figure 9. By Type - Global BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global BCG and Tuberculosis Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global BCG and Tuberculosis Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global BCG and Tuberculosis Vaccine Price (US$/Unit), 2018-2029
Figure 13. By Application - Global BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global BCG and Tuberculosis Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global BCG and Tuberculosis Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global BCG and Tuberculosis Vaccine Price (US$/Unit), 2018-2029
Figure 17. By Region - Global BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global BCG and Tuberculosis Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global BCG and Tuberculosis Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global BCG and Tuberculosis Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America BCG and Tuberculosis Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America BCG and Tuberculosis Vaccine Sales Market Share, 2018-2029
Figure 23. US BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe BCG and Tuberculosis Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe BCG and Tuberculosis Vaccine Sales Market Share, 2018-2029
Figure 28. Germany BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia BCG and Tuberculosis Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia BCG and Tuberculosis Vaccine Sales Market Share, 2018-2029
Figure 37. China BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America BCG and Tuberculosis Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America BCG and Tuberculosis Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa BCG and Tuberculosis Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa BCG and Tuberculosis Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE BCG and Tuberculosis Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global BCG and Tuberculosis Vaccine Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production BCG and Tuberculosis Vaccine by Region, 2022 VS 2029
Figure 54. BCG and Tuberculosis Vaccine Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ BCG&結核ワクチンの世界市場見通し2023年-2029年(BCG and Tuberculosis Vaccine Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 結核（TB）用BCGワクチンの世界市場見通し2023年-2029年
  • IPVワクチンの世界市場見通し2023年-2029年
  • 帯状疱疹ワクチンの世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆